Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CCG Investor Relations is a leading global investor relations and strategic communications firm with a specialized focus on the life sciences, biotechnology, and healthcare sectors. The firm provides a comprehensive suite of services including financial communications, IPO advisory, shareholder identification, and crisis management for emerging growth companies. CCG is particularly well-known for its expertise in cross-border IR, frequently representing Asia-based healthcare companies listed on US exchanges such as NASDAQ and the NYSE. By leveraging deep industry knowledge and an extensive network of institutional investors, CCG helps biotech and pharma companies navigate complex capital markets and enhance their corporate visibility. The firm often operates in close partnership with Elite IR to provide seamless global coverage for its clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CCG Elite Investor Relations.